A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/10/2009	WO2009147221A1 Small molecule leptin receptor modulators
12/10/2009	WO2009147220A1 Pharmaceutical dosage form for immediate release of an indolinone derivative
12/10/2009	WO2009147219A1 New compounds vii
12/10/2009	WO2009147218A1 Pharmaceutical combination
12/10/2009	WO2009147217A1 Dihydro-iso-ca-4 and analogues: potent cytotoxics, inhibitors of tubulin polymerization
12/10/2009	WO2009147216A1 New pyridine derivatives as leptin receptor modulator mimetics
12/10/2009	WO2009147212A1 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
12/10/2009	WO2009147211A1 New compounds v
12/10/2009	WO2009147190A1 Novel compounds
12/10/2009	WO2009147189A1 Novel compounds
12/10/2009	WO2009147188A1 Benzpyrazol derivatives as inhibitors of pi3 kinases
12/10/2009	WO2009147187A1 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases
12/10/2009	WO2009147178A2 Novel medical use of substituted pyridin-2-ylmethylsulphinyl-1h-benzimidazoles
12/10/2009	WO2009147170A2 Drug combinations comprising a dgat inhibitor and a ppar-agonist
12/10/2009	WO2009147169A1 Pharmaceuticl compositions useful for the treatment of cancers, in particular acute myeloid leukemia and acute promyelocytic leukemia
12/10/2009	WO2009147167A1 Indane derivatives as ampa receptor modulators
12/10/2009	WO2009147165A1 Novel ep4 receptor agonist compounds
12/10/2009	WO2009147149A1 Compounds comprising a cyclobutoxy group
12/10/2009	WO2009147144A2 Composition comprising an antibiotic and a corticosteroid
12/10/2009	WO2009147125A1 Dpp-iv inhibitors for use in the treatment of nafld
12/10/2009	WO2009147121A1 Carboxyl substituted indoles for use as ppar alpha modulators
12/10/2009	WO2009147079A1 3,4-dihydropyrimidine trpa1 antagonists
12/10/2009	WO2009147075A2 Pharmaceutical compositions containing a crystalline form of posaconazole
12/10/2009	WO2009146910A1 4, 6-diphenylpyrid-2-0nes against cancer
12/10/2009	WO2009146887A2 Novel treatment of heart diseases
12/10/2009	WO2009146875A1 Pharmaceutical compositions comprising gamma secretase modulators
12/10/2009	WO2009146871A1 5-lipoxygenase inhibitors
12/10/2009	WO2009146811A1 C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter
12/10/2009	WO2009146807A1 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndroms
12/10/2009	WO2009146802A1 Macrocyclic urea and sulfamide derivatives as inhibitors of tafia
12/10/2009	WO2009146772A1 New terpenes and macrocycles
12/10/2009	WO2009146696A1 Use of indole-3-carboxylic esters for inhibiting microsomal prostaglandin e2 synthase
12/10/2009	WO2009146608A1 Pharmaceutical compositions containing imidazole-5-carboxylic acid derivatives and preparation method and use thereof
12/10/2009	WO2009146556A1 Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof
12/10/2009	WO2009146555A1 Hiv integrase inhibitors from pyridoxine
12/10/2009	WO2009146546A1 8-hydroxyquinoline derivatives for the treatment of hematological malignancies
12/10/2009	WO2009146542A1 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith
12/10/2009	WO2009146540A1 N-piperidinyl acetamide derivatives as calcium channel blockers
12/10/2009	WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/10/2009	WO2009146490A1 A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
12/10/2009	WO2009129531A3 Bupivacaine formulation in a polyorthoester carrier
12/10/2009	WO2009129527A3 Baclofen formulation in a polyorthoester carrier
12/10/2009	WO2009129149A3 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
12/10/2009	WO2009129147A3 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
12/10/2009	WO2009128057A3 Growth factor modulators for the treatment of anxiety, depression and cognitive disorders
12/10/2009	WO2009128050A3 An histone deacetylase inhibitor in combination with a sirtuin activator agent for the treatment of neurodegenerativediseases and tumors or neoplasms
12/10/2009	WO2009127922A3 Pharmaceutical formulation for treating cardiovascular disease
12/10/2009	WO2009127869A3 Use of alkyl sulfates or sulfonates against propionibacterium acnes
12/10/2009	WO2009127642A3 Use of lrrk2 inhibitors for neurodegenerative diseases
12/10/2009	WO2009126950A3 Diterpene glycosides as natural solubilizers
12/10/2009	WO2009126682A3 Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
12/10/2009	WO2009125981A3 Pharmaceutical formulation
12/10/2009	WO2009125017A3 Process for the extraction of mangiferin and isomangiferin
12/10/2009	WO2009123575A8 A photosensitising composition and its uses
12/10/2009	WO2009122435A3 Simultaneous preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
12/10/2009	WO2009120712A3 Compositions and methods for diagnosing and treating melanoma
12/10/2009	WO2009119982A3 Adamantine derivative for inhibiting toxicity of amyloid oligomer
12/10/2009	WO2009118759A3 Heterocyclic compounds as adenosine receptor antagonist
12/10/2009	WO2009118754A3 A process for preparing a stable lyophilized composition
12/10/2009	WO2009117401A8 Compositions for site-specific delivery of imatinib and methods of use
12/10/2009	WO2009117335A3 S1p3 receptor inhibitors for treating inflammation
12/10/2009	WO2009116086A3 Topical formulation comprising adapalene microspheres and clindamycin
12/10/2009	WO2009114724A3 COMPOSITIONS COMPRISING NUCLEAR FACTOR-KAPPA B (NF-ĸB) SIRNA AND METHODS OF USE
12/10/2009	WO2009114718A3 Methods and assays for detecting and treating hypoglycemia
12/10/2009	WO2009114685A3 O-desmethylvenlafaxine salts
12/10/2009	WO2009114090A3 Method for inhibiting the build-up of arterial plaque by administering fullerenes
12/10/2009	WO2009114089A3 Using fullerenes to enhance and stimulate hair growth
12/10/2009	WO2009112674A3 Compounds for use in the treatment of neuropathic pain
12/10/2009	WO2009112541A3 Combination therapy with pm00104 and another antitumor agent
12/10/2009	WO2009111785A3 Treatment of sepsis with 5-ethyl-1-phenyl-2(1h)-pyridone and novel methods for synthesis
12/10/2009	WO2009111428A3 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof
12/10/2009	WO2009110983A3 Retinaldehyde in the treatment of obesity, diabetes and other conditions
12/10/2009	WO2009109996A3 Novel cationic amphiphiles with quinic acid head-groups for dna vaccination
12/10/2009	WO2009109990A3 Pramipexole composition comprising sugar alcohol(s)
12/10/2009	WO2009109850A3 N-substitutedbenzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
12/10/2009	WO2009109618A3 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
12/10/2009	WO2009109616A3 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
12/10/2009	WO2009109613A3 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
12/10/2009	WO2009108760A3 Dendritic macroporous hydrogels prepared by crystal templating
12/10/2009	WO2009108384A3 Compounds and compositions that cause non-apoptotic cell death and uses thereof
12/10/2009	WO2009107959A3 Method for separating valuable flavonoid-containing fraction and novel flavonoid substance from above-ground part of the tree named sageretia theezans
12/10/2009	WO2009105774A3 Amino acid inhibitors of cytochrome p450
12/10/2009	WO2009105680A3 Genetic polymorphisms associated with stroke, methods of detection and uses thereof
12/10/2009	WO2009105162A3 Hsp90 inhibitors or modulators for treatment or prevention of substance-related disorders
12/10/2009	WO2009098715A4 Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
12/10/2009	WO2009098008A3 3-(2-dimethylaminomethyl-cyclohexyl)-phenol against polyneuropathic pain
12/10/2009	WO2009097443A3 Liquid formulations of compounds active at sulfonylurea receptors
12/10/2009	WO2009095163A3 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
12/10/2009	WO2009084020A3 Topical composition comprising halobetasol and salicylic acid
12/10/2009	WO2009077677A3 Novel polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same
12/10/2009	WO2009074990A3 Rtp801l sirna compounds and methods of use thereof
12/10/2009	WO2009073138A3 Treatment of metabolic syndrome with novel amides
12/10/2009	WO2009060318A3 Polymorphic forms of ramelteon and processes for preparation thereof
12/10/2009	WO2009059994A3 Methods and compositions for measuring wnt activation and for treating wnt-related cancers
12/10/2009	WO2009055644A3 Agonists and antagonists of guanylate cyclase receptors of the grueneberg ganglion for use in modulating animal behaviour
12/10/2009	WO2009026257A8 Methods and compositions for controlling the bioavailability of poorly soluble drugs
12/10/2009	WO2008149338A3 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
12/10/2009	WO2008148801A8 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
12/10/2009	WO2008147169A8 Microemulsion containing pirfenidone
12/10/2009	WO2008146172A3 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans

1 ... 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 ... 7860